Clinical Benefits & The Löwenstein Difference

S A N T È • LÖW E N S T E I N S L E E P T H E R A PY D E V I C E S

Appendix 6 Pgs. 8-9

New OSA Patient Simulator for Testing PAP Devices

subgroups have been gaining a lot of attention recently because of their clinical relevance. At one end of the age spectrum, elderly patients tend to present with severe OSA and snoring becomes less common. In addition, the frequency of central events increases, although obstruc- tive events still predominate [23]. In contrast, children with OSA have frequent snoring, rest- less sleep, mouth breathing, apneas, gasping, and laboured or paradoxical breathing [24]. With the growing trend towards personalized therapy, specific patient breathing patterns will be increasingly studied as manufacturers work to design the most optimal treatment for each phenotype. One good example of this is OSA in females versus males. It is well-known that the polysomno- graphic features of female OSA are different from those of male OSA. Overall, women have less severe OSA with, on average, a lower AHI [25] and shorter apneas [26]. Women also have more episodes of upper airway events during REM sleep [25]. Body position is far less important for the severity of OSA in women, while OSA severity in men is based more on position than sleep state [25]. Furthermore, women may take longer to fall asleep, but have fewer awakenings during sleep [27]. Regardless of the patient ’ s gender, there is also significant night-to-night variation in OSA, based on factors such as body posture, sleep stages, and previous drug or alcohol intake [28]. Besides OSA pathophysiology, gender influences also patients ’ PAP requirements [29], as generally female patients require lower pressures. Such considerable variability between phenotypes high- lights the relevance of the simulation approach taken in this study. In our optimized bench test we implemented a dynamic pattern ( “ PAP-responsive ” ) simulating a female patient phenotype (although an individual male patient may also present with this OSA pattern), which included long periods of flow limitation, low AHI, and short, low-severity obstructive events. Only three of the APAP devices tested were able to achieve full breathing normalization by overcoming all types of disturbed events including flow limitation. Considering the potential for increased flow limita- tion in female patients, which may lead to breathing disturbances, the effectiveness of treatment in patients presenting with a high component of flow limitation should be carefully examined. Published data comparing different APAP algorithms is scarce, particularly for devices recently launched into the market. Pevernagie et al examined two APAP devices and found that the residual apnea-hypopnea index (AHI) was lower during use of one device compared with the other (3.5±5.6/h vs 9.9±31.0/h), and that the amount of snoring during the night was signifi- cantly higher with one device [30]. A similar study by Nolan et al compared three commercially available devices. The authors found that mean pressure and patient compliance were signifi- cantly lower on one of the APAP devices [17]. Differences between algorithms combined with a lack of information regarding how different auto-adjusting devices work has led to the perception that auto-adjusting devices are a ‘ black box ’ which should be used with caution [31]. In this study, we also found considerable variation among devices in both the magnitude of response to obstructive events, the time taken to increase pressure during disrupted breathing, and device behaviour during the simulated wake period. With the exception of one device, which did not increase the pressure at all, most devices at least slightly increased pressure during simulated wakefulness. Some devices showed quite an intense pressure response during the wake period of the test, with one reaching almost 14 cmH 2 O and two reaching 12 cmH 2 O. Due to the potential impact this could have on patient comfort, pressure changes during wake periods should be assessed in clinical practice, particularly in patients who report difficulties falling asleep while using PAP therapy or issues with comfort at higher PAP pressures. As stated above, our finding of considerable variability in the response of APAP devices when subjected to the same breathing pattern under well-controlled conditions is in agreement with previous reports [19,21,32]. These variations can be attributed to the individual algo- rithms within each APAP device. Each algorithm analyses flow and pressure to determine whether there is a breathing disturbance, and then initiates the most appropriate response to

PLOS ONE | DOI:10.1371/journal.pone.0151530 March 15, 2016

8 / 11

Made with FlippingBook Online newsletter